Klaudin-18 elleni monoklonális ellenanyagok rák kezelésére

• 收藏
• 分享

专利权人:

Ganymed Pharmaceuticals AG;Johannes Gutenberg-Universität Mainz, vertreten durch den Präsidenten

发明人:

SAHIN, Ugur,TUERECI, OEzlem,USENER, Dirk,FRITZ, Stefan,Uherek, Christoph,BRANDENBURG, Gunda,Geppert, Harald-Gerhard,SCHROEDER, Anja Kristina,THIEL, Philippe

申请号：

HUE10011775

公开号：

HUE025578T2

申请日:

2006.11.24

申请国别(地区):

HU

年份:

2016

代理人:

摘要：

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/